{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:21:37Z","timestamp":1793020897084,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cranial irradiation represents one of the first line treatment proposed in skull base meningiomas. While cranial irradiation is associated with a high risk of secondary hypopituitarism, few studies focused on the specific location of skull base meningiomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty-two adults receiving photon-beam therapy for skull base meningiomas between 2003 and 2014 in our Institution were included. Anterior pituitary (ACTH, FSH, GH, LH, TSH and prolactin) as well as corresponding peripheral hormones (8\u2009am-Cortisol, IGF-1, fT3, fT4, 17\u03b2estradiol or testosterone) were biologically screened before radiotherapy (baseline), then yearly until March 2019. The pituitary gland (PG) was delineated on CT and the mean dose delivered to it was calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mean age at diagnosis was 56 +\/\u2212\u200914\u2009years. Median follow-up was 7\u2009years. Up to 60% of patients developed at least \u22652 pituitary deficiencies, 10\u2009years after radiotherapy. Gonadotroph, thyrotroph, corticotroph and somatotroph deficiencies occurred in 37, 28, 18 and 15% of patients, respectively. Hyperprolactinemia was found in 13% of patients. None patient had only one pituitary deficiency. In the multivariate analysis, a delivered dose to the PG\u2009\u2265\u200950\u2009Gy or a meningioma size \u226540\u2009mm significantly increased the risk of developing hypopituitarism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Over a long-term follow-up, cranial radiation therapy used in skull base meningiomas led to a high prevalence of hypopituitarism, further pronounced in case of tumor \u22654\u2009cm. These results advocate for an annual and prolonged follow-up of the pituitary functions in patients with irradiated skull base meningiomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-09045-3","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T12:04:39Z","timestamp":1639829079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["High prevalence of anterior pituitary deficiencies after cranial radiation therapy for skull base meningiomas"],"prefix":"10.1186","volume":"21","author":[{"given":"Perrine","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Salleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bernier-Chastagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"issue":"21","key":"9045_CR1","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2217\/fon-2018-0006","volume":"14","author":"RA Buerki","year":"2018","unstructured":"Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. An overview of meningiomas. Future Oncol Lond Engl. 2018;14(21):2161\u201377.","journal-title":"Future Oncol Lond Engl"},{"issue":"11","key":"9045_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00066-017-1156-3","volume":"193","author":"KA Kessel","year":"2017","unstructured":"Kessel KA, Fischer H, Oechnser M, Zimmer C, Meyer B, Combs SE. High-precision radiotherapy for meningiomas: long-term results and patient-reported outcome (PRO). Strahlenther Onkol Organ Dtsch Rontgengesellschaft. 2017;193(11):921\u201330.","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft"},{"key":"9045_CR3","doi-asserted-by":"crossref","unstructured":"Dufour H, Muracciole X, M\u00e9tellus P, R\u00e9gis J, Chinot O, Grisoli F. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery. f\u00e9vr 2001;48(2):285\u2013294; discussion 294-296.","DOI":"10.1227\/00006123-200102000-00006"},{"issue":"3","key":"9045_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14737175.2018.1429920","volume":"18","author":"C Apra","year":"2018","unstructured":"Apra C, Peyre M, Kalamarides M. Current treatment options for meningioma. Expert Rev Neurother. 2018;18(3):241\u20139.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"9045_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22\u201339.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"9045_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.canrad.2017.09.010","volume":"22","author":"Y Brahimi","year":"2018","unstructured":"Brahimi Y, Antoni D, Srour R, Proust F, Cebula H, Labani A, et al. M\u00e9ningiomes de la base du cr\u00e2ne: efficacit\u00e9 et tol\u00e9rance clinique, efficacit\u00e9 radiologique et cin\u00e9tique tumorale apr\u00e8s radioth\u00e9rapie. Cancer Radioth\u00e9r. 2018;22(3):264\u201386.","journal-title":"Cancer Radioth\u00e9r"},{"issue":"2","key":"9045_CR7","first-page":"186","volume":"106","author":"SE Combs","year":"2013","unstructured":"Combs SE, Adeberg S, Dittmar J-O, Welzel T, Rieken S, Habermehl D, et al. Skull base meningiomas: long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). Radiother Oncol J Eur Soc Ther Radiol. Oncol. 2013;106(2):186\u201391.","journal-title":"Oncol."},{"issue":"9254","key":"9045_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet Lond Engl. 2001;357(9254):425\u201331.","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"9045_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12020-016-1159-3","volume":"56","author":"S Jasim","year":"2017","unstructured":"Jasim S, Alahdab F, Ahmed AT, Tamhane S, Prokop LJ, Nippoldt TB, et al. Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine. 2017;56(1):33\u201342.","journal-title":"Endocrine"},{"issue":"5","key":"9045_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3171\/2009.8.JNS09201","volume":"112","author":"S Vadivelu","year":"2010","unstructured":"Vadivelu S, Sharer L, Schulder M. Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. J Neurosurg. 2010;112(5):920\u20134.","journal-title":"J Neurosurg"},{"issue":"3","key":"9045_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307\u201314.","journal-title":"J Neurooncol"},{"issue":"6","key":"9045_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","volume":"55","author":"M Regal","year":"2001","unstructured":"Regal M, P\u00e1ramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001;55(6):735\u201340.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"9045_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/cen.12969","volume":"84","author":"N Kyriakakis","year":"2016","unstructured":"Kyriakakis N, Lynch J, Orme SM, Gerrard G, Hatfield P, Loughrey C, et al. Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours. Clin Endocrinol (Oxf). 2016;84(3):372\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"262","key":"9045_CR14","first-page":"145","volume":"70","author":"MD Littley","year":"1989","unstructured":"Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med. 1989;70(262):145\u201360.","journal-title":"Q J Med"},{"issue":"1","key":"9045_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0950-351X(05)80321-0","volume":"4","author":"MD Littley","year":"1990","unstructured":"Littley MD, Shalet SM, Beardwell CG. Radiation and hypothalamic-pituitary function. Baillieres Clin Endocrinol Metab. 1990;4(1):147\u201375.","journal-title":"Baillieres Clin Endocrinol Metab"},{"issue":"4","key":"9045_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0360-3016(00)01387-0","volume":"49","author":"HH Pai","year":"2001","unstructured":"Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, et al. Hypothalamic\/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001;49(4):1079\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"9045_CR17","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1210\/jc.2011-0306","volume":"96","author":"NM Appelman-Dijkstra","year":"2011","unstructured":"Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, Neelis KJ, Biermasz NR, Romijn JA, et al. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab ao\u00fbt. 2011;96(8):2330\u201340.","journal-title":"J Clin Endocrinol Metab ao\u00fbt"},{"key":"9045_CR18","doi-asserted-by":"crossref","unstructured":"Lamba N, Bussiere MR, Niemierko A, Abedi P, Fullerton BC, Loeffler JS, et al. Hypopituitarism following cranial irradiation for meningiomas: a single-institution experience. Pract Radiat Oncol:2019.","DOI":"10.1016\/j.prro.2019.01.009"},{"issue":"9","key":"9045_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/adc.67.9.1107","volume":"67","author":"AL Ogilvy-Stuart","year":"1992","unstructured":"Ogilvy-Stuart AL, Clark DJ, Wallace WH, Gibson BE, Stevens RF, Shalet SM, et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child sept. 1992;67(9):1107\u201310.","journal-title":"Arch Dis Child sept"},{"issue":"28","key":"9045_CR20","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1200\/JCO.2018.78.1492","volume":"36","author":"RE Vatner","year":"2018","unstructured":"Vatner RE, Niemierko A, Misra M, Weyman EA, Goebel CP, Ebb DH, et al. Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors. J Clin Oncol Off J Am Soc Clin Oncol. 2018;36(28):2854\u201362.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"9045_CR21","unstructured":"Masson E. Anatomie et histologie de l\u2019hypophyse humaine [Internet]. EM-Consulte. [cit\u00e9 7 sept 2019]. Disponible sur: https:\/\/www.em-consulte.com\/article\/60787\/anatomie-et-histologie-de-l-hypophyse-humaine"},{"key":"9045_CR22","doi-asserted-by":"crossref","unstructured":"Franco L, Williams FMK, Trofimov S, Malkin I, Surdulescu G, Spector T, et al. Assessment of age-related changes in heritability and IGF-1 gene effect on circulating IGF-1 levels. Age. 2014;36(3) [cit\u00e9 7 sept 2019]Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4082604\/.","DOI":"10.1007\/s11357-014-9622-7"},{"issue":"2","key":"9045_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11102-007-0028-8","volume":"10","author":"AYM Kwan","year":"2007","unstructured":"Kwan AYM, Hartman ML. IGF-I measurements in the diagnosis of adult growth hormone deficiency. Pituitary. 2007;10(2):151\u20137.","journal-title":"Pituitary."},{"issue":"1","key":"9045_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1515\/CCLM.2010.009","volume":"48","author":"N Friedrich","year":"2010","unstructured":"Friedrich N, Krebs A, Nauck M, Wallaschofski H. Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the Immulite 2500: results of the study of health in Pomerania (SHIP). Clin Chem Lab Med. 2010;48(1):115\u201320.","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"9045_CR25","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0026-0495(86)90245-3","volume":"35","author":"HR Fish","year":"1986","unstructured":"Fish HR, Chernow B, O\u2019Brian JT. Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review. Metabolism. 1986;35(8):763\u201380.","journal-title":"Metabolism"},{"key":"9045_CR26","doi-asserted-by":"crossref","unstructured":"Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the growth hormone research society workshop on adult growth hormone deficiency. J Clin Endocrinol Metab f\u00e9vr 1998;83(2):379\u2013381.","DOI":"10.1210\/jc.83.2.379"},{"issue":"7","key":"9045_CR27","first-page":"2350","volume":"83","author":"E Erturk","year":"1998","unstructured":"Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab. 1998;83(7):2350\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9045_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s12885-020-07091-x","volume":"20","author":"P Mehta","year":"2020","unstructured":"Mehta P, Janssen S, Fahlbusch FB, Schmid SM, Gebauer J, Cremers F, et al. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study. BMC Cancer. 2020;20(1):610.","journal-title":"BMC Cancer"},{"issue":"2","key":"9045_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1056\/NEJM199301143280211","volume":"328","author":"SM Shalet","year":"1993","unstructured":"Shalet SM. Radiation and Pituitary Dysfunction. N Engl J Med. 1993;328(2):131\u20133.","journal-title":"N Engl J Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-09045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-09045-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-09045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T12:05:54Z","timestamp":1639829154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-09045-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9045"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-09045-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-244899\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been declared to the French National Commission on Information Technology and Liberties (CNIL) on April 122,019 and has been registered by the Data Protection Officer of the Cancer Institute of Lorraine French Region (Number 165). According to the CNIL MR004 compliance declaration, all patients are informed of the potential retrospective use of their clinical data for research purpose and of their right to refuse. Individual written consent was consequently waived in light of those elements. The study was approved by the scientific and ethical committee of the Institut de Canc\u00e9rologie de Lorraine, Nancy, France.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1346"}}